MECP2 and psoriasis: Our results indicate that epigenetic regulation, which potentially involves MECP2 and DNA methylation, may contribute to the altered inflammatory response of the non-lesional psoriatic skin, which may be a psoriasis-specific, disease-severity-dependent para-inflammatory state.